Page last updated: 2024-09-02

2'-5'-oligoadenylate trimer and Granulocytic Leukemia, Chronic

2'-5'-oligoadenylate trimer has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brugger, W; Kalaycio, ME; Li, G; Lichtin, AE; Maitra, RK; Maran, A; Paranjape, JM; Silverman, RH; Torrence, PF; Waller, CF; Xiao, W; Zhang, K	1
Adah, SA; Bayly, SF; Cramer, H; Silverman, RH; Torrence, PF	1

Other Studies

2 other study(ies) available for 2'-5'-oligoadenylate trimer and Granulocytic Leukemia, Chronic

Article	Year
2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells. Blood, 1998, Dec-01, Volume: 92, Issue:11 Topics: Adenine Nucleotides; Endoribonucleases; Enzyme Activation; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oligonucleotides, Antisense; Oligoribonucleotides; Recombinant Fusion Proteins; RNA, Messenger; Tumor Cells, Cultured	1998
Chemistry and biochemistry of 2',5'-oligoadenylate-based antisense strategy. Current medicinal chemistry, 2001, Volume: 8, Issue:10 Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Antiviral Agents; Apoptosis; Carrier Proteins; Endoribonucleases; Gene Expression Regulation, Viral; Humans; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oligoribonucleotides; Oligoribonucleotides, Antisense; Respiratory Syncytial Viruses; RNA Viruses; Sequence Homology, Nucleic Acid; Tumor Cells, Cultured	2001

Article

Year

2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.

Blood, 1998, Dec-01, Volume: 92, Issue:11

Topics: Adenine Nucleotides; Endoribonucleases; Enzyme Activation; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oligonucleotides, Antisense; Oligoribonucleotides; Recombinant Fusion Proteins; RNA, Messenger; Tumor Cells, Cultured

1998

Chemistry and biochemistry of 2',5'-oligoadenylate-based antisense strategy.

Current medicinal chemistry, 2001, Volume: 8, Issue:10

Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Antiviral Agents; Apoptosis; Carrier Proteins; Endoribonucleases; Gene Expression Regulation, Viral; Humans; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oligoribonucleotides; Oligoribonucleotides, Antisense; Respiratory Syncytial Viruses; RNA Viruses; Sequence Homology, Nucleic Acid; Tumor Cells, Cultured

2001